EMBC 13.55 Embecta Corp.
| Range: | 9.925-19.79 | Vol Avg: | 412742 | Last Div: | 0.6 | Changes: | 0.35 |
| Beta: | 0.95 | Cap: | 0.74B | Currency: | USD | Exchange: | NASDAQ |
| Sector: | Healthcare | IPO: | Tue Mar 22 2022 | Empoloyees: | 2200 | ||
| CUSIP: | 29082K105 | CIK: | 0001872789 | ISIN: | US29082K1051 | Country: | US |
| CEO: | Mr. Devdatt Kurdikar | Website: | https://www.embecta.com | ||||
Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey. Embecta Corp.(NasdaqGS:EMBC) operates independently of Becton, Dickinson and Company as of April 1, 2022.
Stock Details
About The Monevue
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
• Powered by StackThrow